Association Is Not CausationLooking Deeper into the Melatonin–Heart Failure Study
- John Kim
- 1 hour ago
- 5 min read
Association Is Not Causation
Looking Deeper into the Melatonin–Heart Failure Study
Yoon Hang Kim, MD, MPH
Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician
Important: This article is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider before making changes to your supplement regimen.
The Headline vs. the Evidence
If you follow health news, you may have seen some alarming headlines recently: "Melatonin linked to heart failure." For many of my clients — people who rely on melatonin as a safe, non-habit-forming sleep aid — this kind of headline is genuinely unsettling. But as is so often the case, what the study actually found and what the headline implies are two very different things.
Let's walk through what this research really showed, where its limitations lie, and what it means for you practically.
What the Study Actually Found
The analysis in question was a retrospective electronic health record (EHR) cohort study presented as an abstract at an American Heart Association (AHA) scientific session. The researchers used a large database called TriNetX to compare people who had documented long-term melatonin use against those who did not. After propensity-score matching — a statistical technique designed to make the two groups more comparable on recorded characteristics — they found that the melatonin group had a higher incidence of heart failure over five years: roughly 5% versus 3%, with a hazard ratio of 1.89.
That is a real statistical association. It is not evidence that melatonin caused heart failure.
The distinction matters enormously — and it is the single most important thing to understand about this study.
Why Association Is Not Causation
In epidemiology, we learn early that observing two things happening together does not tell us that one caused the other. The classic example: ice cream sales and drowning rates both rise in summer. Ice cream does not cause drowning. A shared factor — warm weather — drives both. This same logic applies here.
Propensity matching can adjust for measured variables: age, sex, comorbidities, medications, lab values, and healthcare utilization patterns. That is valuable, and to the researchers' credit, the association persisted even under a stricter prescription-fill definition. But matching cannot account for what it cannot see.
The Confounders Hiding in Plain Sight
The most significant concern is what epidemiologists call confounding by indication — the idea that the very reason someone takes melatonin long-term may itself be the thing that raises their heart failure risk.
Think about who uses melatonin chronically. These are often people dealing with:
Severe, treatment-resistant insomnia
Anxiety or depression
Chronic pain syndromes
Shift-work schedules that disrupt circadian rhythm
Undiagnosed or undertreated sleep apnea
Neurocognitive conditions
General frailty or aging-related sleep disruption
Every single one of these conditions is independently associated with cardiovascular risk. If the melatonin group was enriched for these burdens — and it almost certainly was, because those are the reasons people take melatonin long-term — then the heart failure signal may reflect the underlying conditions, not the supplement.
Other Limitations Worth Knowing
Exposure misclassification. Melatonin is available over the counter. Many people in the "non-user" group may have been taking it — they just never told their doctor. The study could not capture dose, formulation, timing, or adherence with any precision. When you cannot clearly define who is actually exposed and who is not, your results become unreliable.
Reverse causation. Heart failure does not appear overnight. In its early, undiagnosed stages, it can cause fluid retention, nocturnal dyspnea, and disrupted sleep — all of which might lead someone to start taking melatonin. In that case, melatonin use would be a marker of evolving heart disease rather than a cause of it.
Outcome validity. The heart failure "outcome" was an ICD billing code in an EHR. These codes are used for administrative purposes and are not the same as independently verified, clinician-adjudicated diagnoses. The particularly striking difference in heart failure hospitalizations between groups raises questions about whether the groups had different baseline vulnerabilities or different patterns of healthcare contact.
Abstract-level evidence. This was a conference presentation, not a published peer-reviewed manuscript. The full methods, covariate definitions, missing-data handling, and subgroup analyses have not yet been subjected to formal peer scrutiny.
What Would It Take to Prove Causation?
If researchers want to move beyond association, the next logical step would be a well-designed prospective cohort study: enroll people when they first start melatonin, compare them to clinically similar people starting a different sleep strategy, measure dose and adherence carefully, account for sleep apnea and insomnia severity, and follow them forward with independently verified heart failure outcomes.
The gold standard would be a randomized controlled trial — melatonin versus placebo in a defined insomnia population, with blinded, adjudicated outcomes. Randomization handles both measured and unmeasured confounding. But heart failure events are uncommon enough that such a trial would need to be very large and very long, making it expensive and logistically challenging.
Until that work is done, this study gives us a safety signal. It does not give us a conclusion.
What This Means for You
If you are my client and you take melatonin, this study is not a reason to panic. But it is a reasonable prompt to reflect on a few things:
Why are you taking it? If the answer is "I've been taking it for years and never questioned it," that deserves a conversation. Chronic supplement use without periodic reassessment is common, and it is worth revisiting the rationale.
Have underlying sleep issues been addressed? If melatonin is masking untreated sleep apnea, anxiety, or circadian disruption, the right move is to address the root cause — not simply add a nightly supplement indefinitely.
Dose and duration matter. Most over-the-counter melatonin is dosed far higher than what the body produces physiologically. Working with a knowledgeable clinician to find the lowest effective dose — or to explore whether you still need it at all — is prudent.
Melatonin remains, by the available evidence, one of the safest sleep-supporting supplements. This study does not change that conclusion — but it does remind us that no supplement should be taken on autopilot forever.
The Right Question to Ask
A good way to think critically about studies like this is to ask: What characteristic could lead someone to use melatonin long-term AND independently raise their risk of heart failure — even after the statistical adjustments?
If you can think of even one plausible answer (and we listed several above), then you have identified a reason to be cautious about drawing causal conclusions from this data.
Headlines are designed to get clicks. Your health decisions deserve more nuance than a headline can offer.
About Dr. Kim
Yoon Hang Kim, MD, MPH, is board-certified in Preventive Medicine with over 20 years of experience in integrative and functional medicine. A graduate of the University of Arizona Center for Integrative Medicine's prestigious Osher Fellowship under Dr. Andrew Weil, Dr. Kim holds certifications in preventive medicine, medical acupuncture, and integrative and functional medicine. He specializes in low-dose naltrexone (LDN), autoimmune conditions, chronic pain, integrative oncology, fibromyalgia, chronic fatigue syndrome, mast cell activation syndrome (MCAS), and mold-related illness.
Dr. Kim is the author of MCAS: Epidemic in Plain Sight and LDN Primer, both available on Amazon, and the founder of the LDN Support Group. He has published over 20 peer-reviewed articles and authored multiple clinical texts on integrative approaches.
Professional: www.yoonhangkim.com | Clinical: www.directintegrativecare.com
Comments